SCHEMBL13540696

SCHEMBL13540696

CCC(C)C(CN1CCC(O)CC1)NCc1ccc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HTT P42858 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ KCNH2 Q12809 3/20 0.40
▸ MCHR1 Q99705 2/20 0.40
▸ HRH1 P35367 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ CACNA1I Q9P0X4 1/20 0.36
▸ DPP7 Q9UHL4 1/20 0.36
▸ CACNA1G O43497 1/20 0.35
▸ CACNA1B Q00975 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906611 0.91 HRH1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
SCHEMBL13540691 0.72 ALDH1A1 (0.47) ALDH1A1SIGMAR1
SCHEMBL4712429 0.71 KMT2A (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
SCHEMBL9906714 0.67 SLC2A1 (0.39) ALDH1A1KMT2ASMN1; SMN2POLBKCNH2
SCHEMBL9906610 0.64 DRD2 (0.46) ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL11638310 0.63 HTT (0.57) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
Hydrochloric Acid SCHEMBL11635578 0.62 L3MBTL1 (0.69) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
SCHEMBL2056342 0.62 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
SCHEMBL5148167 0.60 HRH3 (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2KCNH2
SCHEMBL28369135 0.60 HTT (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652039-B2 Such as 1-(2-((3-(4-chlorophenoxy)benzyl)amino)-3-phenyl-propyl)piperidin-4-ol for treatment of tuberculosis; solid phase synthesis SEQUELLA, INC. (US) 2010-01-26 — — US disclosed
Send feedback